Monte Rosa Therapeutics Inc (GLUE)
SG&A Expense Growth
-0.40%
Quarterly · Period ending:
GLUE SG&A Expense Growth
Latest reported-0.40%period ending
Latest reported-0.40%period ending
GLUE Quarterly SG&A Growth (QoQ) (0.00% → -0.40%)
Latest values, visible window
High-resolution chart · PNG
GLUE sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -0.4029% | |
| -3.2519% | |
| 16.0177% | |
| 11.9827% | |
| -6.9861% | |
| -0.8431% | |
| 7.998% | |
| -12.4434% | |
| 3.3055% | |
| 16.2655% | |
| -10.7724% | |
| 6.3352% | |
| 8.5421% | |
| -1.5352% | |
| 8.5613% | |
| 11.5171% | |
| -1.4404% | |
| 21.4951% | |
| 10.6038% | |
| 36.3454% | |
| 56.2528% | |
| 7.6218% | |
| 126.8053% | |
| 68.9464% | |
| 13.1799% | |
| 0% |